SEC Form 4 · accession 0000899243-19-006334
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Volker Knappertz
Officer — Chief Medical Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 9:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Mar 1, 2019 | S | 3,732 | $14.46 | D | 8,736 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3,F4,F5 | $14.33 | Mar 1, 2019 | A | 48,252 | A | Mar 1, 2022 | Mar 1, 2029 | Ordinary Shares | 48,252 | 48,252 | D |
| Stock OptionsF3,F6 | $0.0013 | Mar 1, 2019 | A | 91,584 | A | Mar 1, 2022 | Mar 15, 2023 | Ordinary Shares | 91,584 | 91,584 | D |
| Stock OptionsF3,F6,F7 | $0.0013 | Mar 1, 2019 | A | 6,864 | A | Mar 1, 2020 | — | Ordinary Shares | 6,864 | 6,864 | D |
| Stock OptionsF3,F6,F7 | $0.0013 | Mar 1, 2019 | A | 6,864 | A | Mar 1, 2021 | — | Ordinary Shares | 6,864 | 6,864 | D |
| Stock OptionsF3,F6,F7 | $0.0013 | Mar 1, 2019 | A | 6,864 | A | Mar 1, 2022 | — | Ordinary Shares | 6,864 | 6,864 | D |
| Stock OptionsF3,F6,F7 | $0.0013 | Mar 1, 2019 | A | 6,864 | A | Mar 1, 2023 | — | Ordinary Shares | 6,864 | 6,864 | D |
Explanation of responses
- F1Represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- F2The price reported in Column 4 is price per ordinary share converted from price per ADS.
- F3Granted pursuant to the Issuer's Long-Term Incentive Plan.
- F4The reported options are options to purchase ADSs.
- F5The exercise price reported is price per ordinary share converted from price per ADS ($172.01).
- F6Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.32 U.S. Dollars as of March 1, 2019.
- F7These stock options will vest automatically on exercisable date.